Satvat Ali J.

Satvat Ali J. is listed in filings as Director at Coherus Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2026, including 4 public disclosures. Recent filings connect the profile to Coherus Oncology, Inc. (CHRS) and BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Jun 13, 2025 to Jun 9, 2026. Reported amounts are shown as $87.0K to $351.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.